首页> 外文期刊>Journal of orthopaedic trauma >Use of tissue ultrafiltration for treatment of compartment syndrome: a pilot study using porcine hindlimbs.
【24h】

Use of tissue ultrafiltration for treatment of compartment syndrome: a pilot study using porcine hindlimbs.

机译:组织超滤治疗车厢综合症的应用:使用猪后肢的初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To demonstrate the efficacy of compartment syndrome ultrafiltration for the treatment of acute compartment syndrome in an animal model. Our hypothesis is the removal of interstitial fluid will result in a reduction of intramuscular pressure compared with untreated controls in a model of bilateral induced compartment syndrome. DESIGN: Controlled experimental model. SETTING: Animal research facility. PATIENTS/PARTICIPANTS: Three pairs of porcine hindlimbs. INTERVENTION: Acute compartment syndrome was created in the pig hindlimb by infusion of saline to maintain the intramuscular pressure 30 mm Hg greater than the animal's mean arterial pressure for 8 hours. After a 2-hour reperfusion interval, ultrafiltration (removal of fluid through 1 mm diameter porous catheters, connected to -500 mm Hg suction) was commenced in 1 limb only and continued for 9.5 hours. MAIN OUTCOME MEASURES: Intramuscular pressure, ultrafiltrate volume, ultrafiltrate and serum levels of creatine kinase and lactate dehydrogenase, histologic measurement of extracellular and intracellular edema, as well as the degree of cellular necrosis. RESULTS: Intramuscular pressure tended to be lower on the treated side at the end of the treatment period [treated leg: 9.3 +/- 4.0 mm Hg (+/- SE), control leg: 19.3 +/- 1.4 mm Hg, P = 0.03]. Analysis of ultrafiltrate fluid showed that levels of creatine kinase and lactate dehydrogenase were elevated compared with serum levels. Creatine kinase levels in serum were measured at 4150 +/- 780 U/L, whereas ultrafiltrate levels of creatine kinase were 28,700 +/- 17,700 U/L (+/- SE) (P = 0.1). Lactate dehydrogenase was measured at 1950 +/- 180 U/L in serum, but markedly elevated in ultrafiltrate [160,000 +/- 88,900 U/L (+/- SE), P = 0.05]. Quantification of cellular and interstitial dimensions showed no difference in control and experimental limbs. Quantification of the degree of muscle necrosis revealed 6.1 +/- 2.7% necrosis in the treated limb compared to 11.3 +/- 1.6% necrosis in the controlgroup (P = 0.02, df = 2, 1-tailed paired t test). CONCLUSION: This pilot study demonstrates the feasibility of tissue ultrafiltration for reduction of intramuscular pressure in this porcine model. Further studies are underway. Compartment syndrome ultrafiltration may be useful prophylactically in patients at risk for acute compartment syndrome. Sampling of interstitial fluid and frequent measurement of intramuscular pressure may allow earlier diagnosis and treatment of acute compartment syndrome, whereas the reduction of tissue pressure by compartment syndrome ultrafiltration may prevent acute compartment syndrome from occurring. Additionally, compartment syndrome ultrafiltration will not hinder the ability of clinicians to use the clinical examination and pressure monitoring as the gold standard.
机译:目的:证明隔室综合征超滤治疗动物模型急性隔室综合征的功效。我们的假设是,在双边诱发的室间隔综合征模型中,与未治疗的对照组相比,去除组织液会导致肌内压降低。设计:受控实验模型。地点:动物研究设施。患者/受试者:三对猪后肢。干预:猪后肢输注盐水以使肌内压比动物平均动脉压高30 mm Hg,持续8小时,从而导致急性隔室综合征。在2小时的再灌注间隔后,仅在1条肢体中开始超滤(通过直径为1 mm的多孔导管除去液体,连接到-500 mm Hg抽吸口),并持续9.5小时。主要观察指标:肌内压,肌酸激酶和乳酸脱氢酶的超滤液量,超滤液和血清水平,细胞外和细胞内水肿的组织学测量以及细胞坏死的程度。结果:在治疗期结束时,被治疗侧的肌内压趋于降低[治疗腿:9.3 +/- 4.0 mm Hg(+/- SE),对照腿:19.3 +/- 1.4 mm Hg,P = 0.03]。超滤液的分析表明,与血清水平相比,肌酸激酶和乳酸脱氢酶水平升高。血清中的肌酸激酶水平为4150 +/- 780 U / L,而肌酸激酶的超滤液水平为28,700 +/- 17,700 U / L(+/- SE)(P = 0.1)。血清中的乳酸脱氢酶测定值为1950 +/- 180 U / L,但超滤液中的乳酸脱氢酶明显升高[160,000 +/- 88,900 U / L(+/- SE),P = 0.05]。细胞和间质尺寸的定量显示对照组和实验肢无差异。肌肉坏死程度的定量显示,治疗组肢体坏死为6.1 +/- 2.7%,而对照组为11.3 +/- 1.6%坏死(P = 0.02,df = 2,一尾配对t检验)。结论:该初步研究证明了在该猪模型中组织超滤降低肌肉内压力的可行性。进一步的研究正在进行中。室综合征超滤可能在有急性室综合征风险的患者中预防使用。取组织液取样并频繁测量肌内压可允许早期诊断和治疗急性室综合征,而通过室综合征超滤降低组织压力可防止急性室综合征的发生。另外,隔室综合征超滤不会妨碍临床医生使用临床检查和压力监测作为金标准的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号